Heidelberg Pharma AG (ETR:HPHA)

PRESS RELEASE

published on 11/24/2025 at 15:04, 9 months 4 days ago

EQS-Adhoc: Heidelberg Pharma Announces Changes to the Executive Management Board - Dr Dongzhou Jeffery Liu Appointed as Chairman of the Executive Board and Chief Executive Officer
Heidelberg Pharma AG announces changes to the Executive Management Board - Dr. Dongzhou Jeffery Liu appointed as Chairman of the Executive Board and Chief Executive Officer

Chairman CEO Heidelberg Pharma AG Executive Management Board Dr. Dongzhou Jeffery Liu
BRIEF

published on 11/06/2025 at 07:14, 9 months 22 days ago

Essai clinique sur le HDP-101 d'Heidelberg Pharma dans le myélome multiple

Essai Clinique Heidelberg Pharma HDP-101 Myélome Multiple Technologie ATAC
BRIEF

published on 11/06/2025 at 07:14, 9 months 22 days ago

Heidelberg Pharma's HDP-101 Advances in Multiple Myeloma Trial

Clinical Trial Heidelberg Pharma HDP-101 Multiple Myeloma ATAC Technology
PRESS RELEASE

published on 11/06/2025 at 07:09, 9 months 22 days ago

Heidelberg Pharma’s Lead ATAC Candidate HDP-101 Shows Progress in Phase I/IIa Trial in Multiple Myeloma
Heidelberg Pharma's lead ATAC candidate HDP-101 shows promising progress in Phase I/IIa trial for multiple myeloma, including stringent complete remissions. R&D webinar scheduled on 11 Nov 2025

Heidelberg Pharma HDP-101 Multiple Myeloma ATAC Candidate Phase I/IIa Trial
BRIEF

published on 11/03/2025 at 10:12, 9 months 25 days ago

Heidelberg Pharma Reveals Promising Data for HDP-101 at ADC Congress 2025

Clinical Data Heidelberg Pharma HDP-101 Multiple Myeloma ADC Congress
BRIEF

published on 11/03/2025 at 10:12, 9 months 25 days ago

Heidelberg Pharma présente des données prometteuses sur le HDP-101 lors du congrès ADC 2025

Heidelberg Pharma HDP-101 Myélome Multiple Données Cliniques Congrès ADC
PRESS RELEASE

published on 11/03/2025 at 10:07, 9 months 25 days ago

Heidelberg Pharma to Present New Clinical Data of Lead ADC Candidate HDP-101 at the World ADC Congress 2025 and to Host Webinar
Heidelberg Pharma to present new clinical data of lead ADC candidate HDP-101 at the World ADC Congress 2025 and host a webinar. Study results show promising anti-tumor activity in multiple myeloma patients

Webinar Clinical Data Heidelberg Pharma Multiple Myeloma ADC Candidate
BRIEF

published on 10/23/2025 at 08:02, 10 months 5 days ago

Heidelberg Pharma's HDP-101 Receives Fast Track Designation from FDA

FDA Heidelberg Pharma HDP-101 Multiple Myeloma Fast Track Designation
BRIEF

published on 10/23/2025 at 08:02, 10 months 5 days ago

Le HDP-101 de Heidelberg Pharma reçoit la désignation accélérée de la FDA

FDA Heidelberg Pharma HDP-101 Myélome Multiple Désignation Accélérée
PRESS RELEASE

published on 10/23/2025 at 07:57, 10 months 5 days ago

Heidelberg Pharma’s Lead ADC Candidate HDP-101 Granted Fast Track Designation by US FDA for the Treatment of Multiple Myeloma
Heidelberg Pharma's lead ADC candidate HDP-101 granted Fast Track Designation by US FDA for the treatment of multiple myeloma. Accelerated review for innovative cancer therapy

Heidelberg Pharma Multiple Myeloma Fast Track Designation ADC Candidate US FDA

Published on 08/28/2026 at 14:00, 4 hours 12 minutes ago

Lobe Sciences Expands Leadership Team with New CFO Appointment
Published on 08/28/2026 at 13:00, 5 hours 12 minutes ago

Abasca Files NI 43-101 Technical Report, Commences Summer Exploration Program at Loki and Elects to File Semi-annual Interim Financial Statements and Related MD&A
Published on 08/28/2026 at 08:05, 10 hours 7 minutes ago

Caledonia Mining Corporation Plc: Maiden Mineral Resource Estimate at Motapa 379,000 oz Measured and Indicated; 131,000 oz Inferred
Published on 08/28/2026 at 08:05, 10 hours 7 minutes ago

Tocvan Announces New Surface Mineralization in Several Zones at Gran Pilar Gold-Silver Project
Published on 08/28/2026 at 08:00, 10 hours 12 minutes ago

Caledonia Mining Corporation Plc: Blanket Mine Underground Measured and Indicated Mineral Resources Estimate Increases by 22% to 2.18 Million Ounces and Declaration of a Surface Mineral Resource Estimate

View all ACCESSWIRE

Published on 08/28/2026 at 18:01, 10 minutes ago

CPI Europe announces unaudited results for the first half of 2026
Published on 08/28/2026 at 18:00, 12 minutes ago

Highlight Event and Entertainment AG publishes results for the first half of 2026
Published on 08/28/2026 at 18:00, 12 minutes ago

Investis successfully issues a fixed rate bond of CHF 100 million
Published on 08/28/2026 at 18:00, 12 minutes ago

Investis émet avec succès un emprunt obligataire à taux fixe d’un volume de CHF 100 millions
Published on 08/28/2026 at 17:48, 24 minutes ago

TVR-Total Voting Rights

View all EQS

Published on 08/28/2026 at 17:45, 27 minutes ago

STEF : Droits de vote au 31 07 2026
Published on 08/28/2026 at 06:55, 11 hours 17 minutes ago

Recticel Accelerates Profitable Growth
Published on 08/28/2026 at 06:55, 11 hours 17 minutes ago

Recticel versnelt winstgevende groei
Published on 08/26/2026 at 18:02, 2 days ago

Altareit: Altarea press release regarding the Primonial matter
Published on 08/26/2026 at 18:02, 2 days ago

Altareit : Communiqué de presse d’Altarea relatif au dossier Primonial

View all LES ECHOS COMFI WIRE

News